Our previous data indicated that the administration of CO significantly improves HFD-induced hyperlipidemia by reprogramming the gut microbiota composition and inhibiting the mTOR pathway and biosynthesis of lipid-related genes [21]. The gene discussed is MTOR; the disease is hyperlipidemia.